$ALT
Altimmune Inc

2012 Q3 Form 10-Q Financial Statement

#000114420412043389 Filed on August 07, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2012 Q2 2011 Q2
Revenue $6.700M $6.320M $6.430M
YoY Change 27.38% -1.71% 34.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.280M $2.780M $3.410M
YoY Change 0.0% -18.48% -17.23%
% of Gross Profit
Research & Development $5.139M $4.919M $5.984M
YoY Change 5.21% -17.8% 0.74%
% of Gross Profit
Depreciation & Amortization $72.45K $70.00K $110.0K
YoY Change -39.62% -36.36% -56.0%
% of Gross Profit
Operating Expenses $8.487M $7.775M $9.510M
YoY Change 2.47% -18.24% -7.85%
Operating Profit -$1.790M -$1.458M -$3.081M
YoY Change -40.75% -52.68%
Interest Expense $112.5K $111.4K $15.17K
YoY Change 1032.99% 633.89% -101.7%
% of Operating Profit
Other Income/Expense, Net $1.599M $717.8K $643.7K
YoY Change -46.51% 11.51% 2045.69%
Pretax Income -$191.9K -$740.4K -$2.438M
YoY Change 472.8% -69.63% -61.85%
Income Tax $22.07K $16.13K $0.00
% Of Pretax Income
Net Earnings -$213.9K -$756.5K -$2.438M
YoY Change 538.69% -68.96% -61.85%
Net Earnings / Revenue -3.19% -11.97% -37.91%
Basic Earnings Per Share $0.00 -$0.02 -$0.05
Diluted Earnings Per Share $0.00 -$0.02 -$0.05
COMMON SHARES
Basic Shares Outstanding 48.37M shares 48.33M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q3 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.70M $11.80M $14.20M
YoY Change 41.35% -16.9% 1928.57%
Cash & Equivalents $14.73M $11.78M $14.16M
Short-Term Investments
Other Short-Term Assets $400.0K $700.0K $1.400M
YoY Change -75.0% -50.0% 75.0%
Inventory
Prepaid Expenses
Receivables $5.300M $8.200M $7.400M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $20.38M $20.68M $22.90M
YoY Change 11.36% -9.68% 59.03%
LONG-TERM ASSETS
Property, Plant & Equipment $553.1K $625.5K $1.000M
YoY Change -38.55% -37.45% -83.87%
Goodwill $2.348M $2.348M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $130.7K $150.5K $100.0K
YoY Change 30.71% 50.48% 0.0%
Total Long-Term Assets $3.032M $3.124M $3.400M
YoY Change -8.11% -8.1% -64.21%
TOTAL ASSETS
Total Short-Term Assets $20.38M $20.68M $22.90M
Total Long-Term Assets $3.032M $3.124M $3.400M
Total Assets $23.41M $23.81M $26.30M
YoY Change 8.38% -9.48% 10.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.847M $2.063M $2.500M
YoY Change 361.65% -17.49% -70.24%
Accrued Expenses $3.200M $3.100M $3.400M
YoY Change 0.0% -8.82% -20.93%
Deferred Revenue
YoY Change
Short-Term Debt $1.208M $0.00 $0.00
YoY Change
Long-Term Debt Due $681.8K $454.5K
YoY Change
Total Short-Term Liabilities $6.971M $5.659M $5.900M
YoY Change 88.39% -4.08% -53.54%
LONG-TERM LIABILITIES
Long-Term Debt $1.764M $1.984M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $579.7K $564.9K $6.300M
YoY Change -82.95% -91.03% 293.75%
Total Long-Term Liabilities $2.344M $2.548M $6.300M
YoY Change -31.06% -59.55% -69.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.971M $5.659M $5.900M
Total Long-Term Liabilities $2.344M $2.548M $6.300M
Total Liabilities $10.86M $10.26M $12.20M
YoY Change 52.96% -15.88% -63.58%
SHAREHOLDERS EQUITY
Retained Earnings -$197.3M -$197.1M
YoY Change
Common Stock $210.1M $209.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.55M $13.55M $14.10M
YoY Change
Total Liabilities & Shareholders Equity $23.41M $23.81M $26.30M
YoY Change 8.38% -9.48% 10.04%

Cashflow Statement

Concept 2012 Q3 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income -$213.9K -$756.5K -$2.438M
YoY Change 538.69% -68.96% -61.85%
Depreciation, Depletion And Amortization $72.45K $70.00K $110.0K
YoY Change -39.62% -36.36% -56.0%
Cash From Operating Activities $1.730M -$2.700M -$1.300M
YoY Change -147.92% 107.69% -41.18%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$30.00K
YoY Change -100.0% -100.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 -$30.00K
YoY Change -100.0% -100.0% -40.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.100M
YoY Change 127.68%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.210M -810.0K 5.790M
YoY Change -2520.0% -113.99% 158.48%
NET CHANGE
Cash From Operating Activities 1.730M -2.700M -1.300M
Cash From Investing Activities 0.000 0.000 -30.00K
Cash From Financing Activities 1.210M -810.0K 5.790M
Net Change In Cash 2.940M -3.510M 4.460M
YoY Change -179.46% -178.7% -22400.0%
FREE CASH FLOW
Cash From Operating Activities $1.730M -$2.700M -$1.300M
Capital Expenditures $0.00 $0.00 -$30.00K
Free Cash Flow $1.730M -$2.700M -$1.270M
YoY Change -148.46% 112.6% -40.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48365984 shares
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14160598
CY2012Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
46584 shares
CY2012Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.61
CY2012Q1 pip Warrant Expiration Date
WarrantExpirationDate
2022-03-30
CY2012Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
675047
CY2012Q2 us-gaap Goodwill
Goodwill
2348453
CY2012Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
69876
CY2012Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
209662510
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150479
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
909096
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11600000 shares
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-756543
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
CY2012Q2 us-gaap Assets Current
AssetsCurrent
20683102
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48236172 shares
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
13545446
CY2012Q2 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.1014 pure
CY2012Q2 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.015 pure
CY2012Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2900000
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
1003989
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q2 us-gaap Billed Contract Receivables
BilledContractReceivables
3444830
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48345984 shares
CY2012Q2 us-gaap Liabilities
Liabilities
10262122
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2062718
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
564860
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-197125888
CY2012Q2 us-gaap Assets
Assets
23807568
CY2012Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
4786304
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23807568
CY2012Q2 us-gaap Long Term Debt
LongTermDebt
2500000
CY2012Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
216000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11776921
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48345984 shares
CY2012Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
46584 shares
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
909096
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5659213
CY2012Q2 us-gaap Deferred Revenue
DeferredRevenue
19000
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
4835
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
681808
CY2012Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2054505
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
625534
CY2012Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
454548
CY2012Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1983544
CY2012Q2 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3141947
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11785327
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
830585
CY2011Q4 us-gaap Goodwill
Goodwill
2348453
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
208525917
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53384
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
15851806
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
1010522
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q4 us-gaap Billed Contract Receivables
BilledContractReceivables
4424442
CY2011Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
100000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
449709
CY2011Q4 us-gaap Liabilities
Liabilities
6951703
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1445700
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-193689457
CY2011Q4 us-gaap Assets
Assets
22803509
CY2011Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3021208
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22803509
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11236771
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48236172 shares
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4615342
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
500000
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
4824
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2011Q4 us-gaap Assets Current
AssetsCurrent
19613006
CY2011Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1886652
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
788666
CY2011Q4 pip Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3169642
us-gaap Operating Income Loss
OperatingIncomeLoss
-7621255
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-674723
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44628
us-gaap Contracts Revenue
ContractsRevenue
12766562
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4522562
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-64362
us-gaap Share Based Compensation
ShareBasedCompensation
1255325
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3176686
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-1114139
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Depreciation And Amortization
DepreciationAndAmortization
234319
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3385227
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30364
us-gaap Investment Income Interest
InvestmentIncomeInterest
6535
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30364
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2375271
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8349026
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1611860
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-760274
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9292
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4513270
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11804472
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5798196
us-gaap Operating Expenses
OperatingExpenses
20387817
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
404230
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1255325
us-gaap Interest Paid
InterestPaid
30608
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46454968 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48297919 shares
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
166538
us-gaap Net Income Loss
NetIncomeLoss
-4513270
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10900000 shares
us-gaap Net Income Loss
NetIncomeLoss
-3436431
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3107985
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
304000 shares
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-7334
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
400000
us-gaap Interest Expense
InterestExpense
30608
pip Provision And Recovery For Doubtful Accounts
ProvisionAndRecoveryForDoubtfulAccounts
-400695
pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
0 shares
pip Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
5862558
dei Trading Symbol
TradingSymbol
PIP
dei Entity Registrant Name
EntityRegistrantName
PHARMATHENE, INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001326190
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
1.61
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.065 pure
us-gaap Operating Income Loss
OperatingIncomeLoss
-3048900
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
216460
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
617014
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53434
us-gaap Contracts Revenue
ContractsRevenue
12466050
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3442964
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-32960
us-gaap Share Based Compensation
ShareBasedCompensation
1060705
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-220993
us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
Payments on the term loan are interest-only for the first 10 months, which may be extended to 12 months if certain conditions described in the Loan Agreement are met. Subsequently, the term loan will fully amortize over its remaining term.
us-gaap Operating Expenses
OperatingExpenses
15514950
us-gaap Paid In Kind Interest
PaidInKindInterest
40470
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-87483
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
66626
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1060705
us-gaap Interest Paid
InterestPaid
73911
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2500000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
67400
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-167853
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
1765096
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
us-gaap Depreciation And Amortization
DepreciationAndAmortization
162358
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1912379
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
67400
us-gaap Investment Income Interest
InvestmentIncomeInterest
7807
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
100000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
540150
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5728580
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-248707
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-979612
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6533
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3269893
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9624012
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2389563
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
200948 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
166538
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4434
us-gaap Use Of Estimates
UseOfEstimates
<div style="FONT: 10pt Times New Roman, Times, Serif"> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"><i>Use of Estimates</i></p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#xA0;</p> <p style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period.&#xA0;&#xA0;Actual results could differ from those estimates.</p> </div>
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
1000000
us-gaap Interest Expense
InterestExpense
114381
pip Supplemental Warrant Issued In Connection With Long Term Debt
SupplementalWarrantIssuedInConnectionWithLongTermDebt
69876
pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
0 shares
pip Debt Instruments Maturity Date Month And Year
DebtInstrumentsMaturityDateMonthAndYear
2015-09
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
717794
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
185000 shares
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16133
CY2012Q2 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
400000
CY2012Q2 us-gaap Interest Expense
InterestExpense
111353
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2437613
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5984098
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
9510160
CY2011Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
544700
CY2011Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
46631396 shares
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-2437613
CY2011Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
643707
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
208000 shares
CY2011Q2 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
100000
pip Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
38983
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3081320
CY2011Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-32722
CY2011Q2 us-gaap Contracts Revenue
ContractsRevenue
6428840
CY2011Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2423842
CY2011Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
688221
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2011Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
116690
CY2011Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3381
CY2011Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3409372
CY2011Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13771
CY2011Q2 us-gaap Interest Expense
InterestExpense
15173
CY2011Q2 pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
0 shares
CY2011Q2 pip Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate
0.12 pure
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1458204
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
519
CY2012Q2 us-gaap Contracts Revenue
ContractsRevenue
6316998
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-776445
CY2012Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
823809
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2012Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76448
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4819
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2780099
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-19902
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-740410
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4918655
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
7775202
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
512041
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48325945 shares
CY2012Q2 pip Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Units Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsGrantedInPeriod
0 shares
CY2012Q2 pip Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeitureRate
0.12 pure

Files In Submission

Name View Source Status
0001144204-12-043389-index-headers.html Edgar Link pending
0001144204-12-043389-index.html Edgar Link pending
0001144204-12-043389.txt Edgar Link pending
0001144204-12-043389-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
pip-20120630.xml Edgar Link completed
pip-20120630.xsd Edgar Link pending
pip-20120630_cal.xml Edgar Link unprocessable
pip-20120630_def.xml Edgar Link unprocessable
pip-20120630_lab.xml Edgar Link unprocessable
pip-20120630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v318145_10q.htm Edgar Link pending
v318145_ex31-1.htm Edgar Link pending
v318145_ex31-2.htm Edgar Link pending
v318145_ex32-1.htm Edgar Link pending
v318145_ex32-2.htm Edgar Link pending